Merck & Co., Inc.
MRK
$87.37
$1.291.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.78% | -0.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.78% | -0.61% | |||
| Cost of Revenue | 0.27% | -8.74% | |||
| Gross Profit | 2.21% | 1.92% | |||
| SG&A Expenses | 3.83% | -10.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.18% | -9.48% | |||
| Operating Income | -4.79% | 16.48% | |||
| Income Before Tax | -15.31% | 41.56% | |||
| Income Tax Expenses | -30.20% | 92.02% | |||
| Earnings from Continuing Operations | -12.92% | 35.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 83.33% | -500.00% | |||
| Net Income | -12.84% | 35.69% | |||
| EBIT | -4.79% | 16.48% | |||
| EBITDA | -4.01% | 12.77% | |||
| EPS Basic | -12.39% | 36.44% | |||
| Normalized Basic EPS | -5.04% | 19.87% | |||
| EPS Diluted | -12.44% | 36.23% | |||
| Normalized Diluted EPS | -4.85% | 19.49% | |||
| Average Basic Shares Outstanding | -0.52% | -0.55% | |||
| Average Diluted Shares Outstanding | -0.71% | -0.24% | |||
| Dividend Per Share | 0.00% | 5.19% | |||
| Payout Ratio | 0.16% | -0.23% | |||